Share
Market Research Report

DIAGNOSTIC SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Service TypePathology/Laboratory (Clinical Chemistry, Hematology, Microbiology and Cytology, Molecular Diagnostics, Immunodiagnostics/Immunoassay, Others (Histopathology)) · and Radiology/Diagnostic Imaging (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Nuclear Imaging (PET, SPECT), Others (Mammography)) · By Test Type (Routine/Preventive Test, Molecular and Genetic Test, Point-of-Care Tests (POCT), and Other Specialty Test) · By Application (Oncology, Cardiology, Neurology, Gastroenterology, Orthopedics, Gynecology and Obstetrics, and Other Applications (e.g., Infectious Diseases, Endocrinology)) · By End User (Hospitals and Clinics, Diagnostic Laboratories and Pathology Labs, Research and Academic Institutes, Home Healthcare/At-Home Testing, and Specialized Diagnostic Centers) · By Payer (Public, Private, Self-Pay (Out-of-Pocket Patients) and Corporate/Employer-Sponsored Health Plans) · By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • Published In17 Mar 2026
  • Report CodeCMI8663
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  •  Service Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Pathology/Laboratory
      • Clinical Chemistry
      • Hematology
      • Microbiology and Cytology
      • Molecular Diagnostics
      • Immunodiagnostics/Immunoassay
      • Others (Histopathology)
    • Radiology/Diagnostic Imaging
      • X-ray
      • Magnetic Resonance Imaging (MRI)
      • Ultrasound
      • Computed Tomography (CT) Scan
      • Nuclear Imaging (PET, SPECT)
      • Others (Mammography)
  • Test Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Routine/Preventive Test
    • Molecular and Genetic Test
    • Point-of-Care Tests (POCT)
    • Other Specialty Test
  • Application Insights (Revenue, USD Bn, 2021 - 2033)

    • Oncology
    • Cardiology
    • Neurology
    • Gastroenterology
    • Orthopedics
    • Gynecology and Obstetrics
    • Other Applications (e.g., Infectious Diseases, Endocrinology)
  • End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Hospitals and Clinics
    • Diagnostic Laboratories and Pathology Labs
    • Research and Academic Institutes
    • Home Healthcare/At-Home Testing
    • Specialized Diagnostic Centers
  • Payer Insights (Revenue, USD Bn, 2021 - 2033)

    • Public
    • Private
    • Self-Pay (Out-of-Pocket Patients)
    • Corporate/Employer-Sponsored Health Plans
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa